Show items per page
Elements: 23
Page 1 on 2
 TitleAuthors / EditorsDate
add to browser selection
Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let's Clear Up That Case With Some Controls Remy, Amandine; Théorêt, Yves; Ansari Djaberi, Marc Georges; Bittencourt, Henrique; ... Kleiber, Niina 2021
add to browser selection
Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience Bernard, Fanette; Uppugunduri Satyanarayana, Chakradhara Rao; Meyer, Stephan; Cummins, Michelle; ... Amrolia, Persis 2021
add to browser selection
Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT Nabergoj, Mitja; Mauff, Katya; Robin, Marie; Kröger, Nicolaus; ... Yakoub-Agha, Ibrahim 2021
add to browser selection
Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT Battipaglia, Giorgia; Mauff, Katya; Wendel, Lotus; Angelucci, Emanuele; ... Yakoub-Agha, Ibrahim 2021
add to browser selection
Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies Peric, Zinaida; Mohty, Razan; Bastos, Juliana; Brissot, Eolia; ... Mohty, Mohamad 2020
add to browser selection
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy? - A multicenter EBMT-PDWP study Willasch, Andre Manfred; Peters, Christina; Sedláček, Petr; Dalle, Jean-Hugues; ... Bader, Peter 2020
add to browser selection
Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy Bradford, Kathryn L; Liu, Siyu; Krajinovic, Maja; Ansari Djaberi, Marc Georges; ... Kohn, Donald B 2020
add to browser selection
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation Buhler, Stéphane; Bettens, Florence; Dantin, Carole Alice; Ferrari-Lacraz, Sylvie; ... Villard, Jean 2020
add to browser selection
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT) Cesaro, Simone; Pillon, Marta; Sauer, Martin; Smiers, Frans; ... Dufour, Carlo 2020
add to browser selection
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation Duléry, Rémy; Bastos, Juliana; Paviglianiti, Annalisa; Malard, Florent; ... Mohty, Mohamad 2019
add to browser selection
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation McLornan, Donal; Szydlo, Richard; Koster, Linda; Chalandon, Yves; ... Yakoub-Agha, Ibrahim 2019
add to browser selection
Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Benz, R; Schanz, U; Maggiorini, M; Seebach, Jorg Dieter; Stussi, G 2014
add to browser selection
The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation Uppugunduri Satyanarayana, Chakradhara Rao; Rezgui, M; Diaz, PH; Tyagi, Anuj Kumar; ... Ansari Djaberi, Marc Georges 2014
add to browser selection
Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients Ansari Djaberi, Marc Georges; Rezgui, MA; Théoret, Y; Uppugunduri Satyanarayana, Chakradhara Rao; ... Krajinovic, M 2013
add to browser selection
No improvement of survival with reduced - versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients Thiel, U 2011
add to browser selection
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 Ljungman, P.; Bregni, M.; Brune, M.; Cornelissen, J.; ... Niederwieser, D. 2010
add to browser selection
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies Stussi, G.; Halter, J.; Tichelli, A.; Meyer-Monard, S.; ... Gratwohl, Alois 2010
add to browser selection
Influence of GST gene polymorphisms on busulfan pharmacokinetics in children Ansari Djaberi, Marc Georges; Lauzon-Joset, J-F; Vachon, M-F; Duval, M.; ... Krajinovic, M. 2010
add to browser selection
T regulatory cells in xenotransplantation Muller, Yannick; Golshayan, Dela; Ehirchiou, Driss; Wekerle, Thomas; ... Buehler, Leo Hans 2009
add to browser selection
Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA Lawler, Mark; McCann, Shaun R.; Marsh, Judith C. W.; Ljungman, Per; ... Bacigalupo, Andrea 2009
<< previous | 1 | 2 |